id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-303417-1237ykxt	d’Arminio Monforte, Antonella	Effectiveness of Hydroxychloroquine in COVID-19 disease: A done and dusted situation?	2020-07-29		.txt	text/plain	659	42	52	Arshad et al show evidence for a reduced mortality in Covid-19 patients taking hydroxychloroquine alone or with azithromycin in an observational study in USA [1] . We divided a subset of our cohort in three groups who started treatment a median of 1 day after admission: those receiving hydroxycholoroquine alone (N=197), those receiving hydroxycholoroquine+azithromycin (N=94), and those receiving neither (controls) (N=92). After adjusting for a number of key confounders (see table) , the use of hydroxycholoroquine+azithromycin was associated with a 66% reduction in risk of death as compared to controls; the analysis also suggested a larger effectiveness of hydroxychloroquine in patients with less severe COVID-19 disease (PO2/FiO2>300, interaction p-value<.0001). Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalised with COVID-19 Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomised clinical trial Hydroxychloroquine in patients mainly with mild to moderate COVID-19: an open-label, randomised, controlled trial An observational cohort study of hydroxychloroquine and azithromycin for COVID-19: (Can't get no) satisfaction	./cache/cord-303417-1237ykxt.txt	./txt/cord-303417-1237ykxt.txt